Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
135.59
Oct 20 • 3:59 PM ET Dollar change+4.07 Percentage change(3.09%)
Aftermarket Close
132.31
Aftermarket • 5:04 PM ET Dollar change-3.28 Percentage change(-2.42%)
Index
RUT
Market Cap
5.13B
Enterprise Value
4.69B
Income
61.76M
Sales
1.03B
Book/sh
42.75
Cash/sh
19.00
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
3000
IPO
Sep 22, 1995
P/E
86.67
Forward P/E
31.05
PEG
-
P/S
4.98
P/B
3.17
P/C
7.14
P/FCF
45.29
EV/EBITDA
25.86
EV/Sales
4.56
Quick Ratio
3.79
Current Ratio
4.57
Debt/Eq
0.18
LT Debt/Eq
0.14
Option/Short
Yes / Yes
EPS (ttm)
1.56
EPS next Y
4.37
EPS next Q
0.97
EPS this Y
12.26%
EPS next Y
18.23%
EPS next 5Y
-
EPS past 3/5Y
-10.74% 2.97%
Sales past 3/5Y
4.43% 10.67%
EPS Y/Y TTM
-7.28%
Sales Y/Y TTM
7.61%
EPS Q/Q
144.54%
Sales Q/Q
10.27%
Insider Own
0.71%
Insider Trans
-11.29%
Inst Own
121.19%
Inst Trans
28.94%
ROA
3.38%
ROE
5.11%
ROIC
3.34%
Gross Margin
41.90%
Oper. Margin
11.65%
Profit Margin
6.00%
SMA20
-4.19%
SMA50
-6.40%
SMA200
-4.22%
Trades
Shs Outstand
37.82M
Shs Float
37.55M
52W High
176.38 -23.12%
52W Low
98.27 37.98%
Volatility
4.52% 4.07%
ATR (14)
6.71
RSI (14)
44.30
Beta
1.72
Rel Volume
1.00
Avg Volume
401.33K
Volume
399,744
Perf Week
-6.84%
Perf Month
0.95%
Perf Quarter
-6.65%
Perf Half Y
2.41%
Perf YTD
13.95%
Perf Year
25.05%
Perf 3Y
0.17%
Perf 5Y
-17.34%
Perf 10Y
672.59%
Prev Close
131.52
Price
135.59
Change %
3.09%
Date Action Analyst Rating Change Price Target Change
Mar-30-26Upgrade Robert W. Baird Neutral → Outperform $144
May-11-22Upgrade William Blair Mkt Perform → Outperform
Nov-13-20Initiated Berenberg Buy $109
Apr-02-20Downgrade William Blair Outperform → Mkt Perform
Feb-27-18Initiated William Blair Outperform
Dec-08-17Initiated Robert W. Baird Outperform $54
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Secor Thomas NDirectorSep 11 '26Sale147.6066397,859662Sep 15 04:06 PM
Secor Thomas NDirectorSep 11 '26Proposed Sale147.6066397,859Sep 11 10:37 AM
Glastra MatthijsChief Executive OfficerJul 02 '26Sale161.136,5001,047,34029,761Jul 07 04:05 PM
Matthijs GlastraOfficerJul 02 '26Proposed Sale161.706,5001,051,050Jul 02 12:29 PM
Glastra MatthijsChief Executive OfficerJun 02 '26Sale168.666,5001,096,27336,261Jun 04 04:05 PM
Matthijs GlastraOfficerMay 12 '26Proposed Sale150.007,5001,125,000Jun 02 04:49 PM
Glastra MatthijsChief Executive OfficerMay 12 '26Sale150.437,5001,128,24442,761May 14 04:06 PM
Matthijs GlastraOfficerMay 12 '26Proposed Sale150.007,5001,125,000May 12 10:41 AM
Glastra MatthijsChief Executive OfficerMay 05 '26Sale131.136,500852,34850,261May 07 04:16 PM
Matthijs GlastraOfficerMay 05 '26Proposed Sale130.006,500845,000May 05 04:14 PM
Glastra MatthijsChief Executive OfficerApr 17 '26Sale130.056,500845,32556,761Apr 21 04:17 PM
Matthijs GlastraOfficerApr 17 '26Proposed Sale130.006,500845,000Apr 17 11:05 AM
Buckley RobertChief Financial OfficerMar 16 '26Option Exercise14.139,957140,692106,573Mar 18 04:49 PM
Buckley RobertChief Financial OfficerMar 16 '26Sale116.779,9571,162,65196,616Mar 18 04:49 PM
Glastra MatthijsChief Executive OfficerMar 02 '26Sale138.346,500899,23963,261Mar 04 04:24 PM
Matthijs GlastraOfficerMar 02 '26Proposed Sale130.006,500845,000Mar 02 04:54 PM
Buckley RobertChief Financial OfficerFeb 20 '26Option Exercise14.131,42320,10795,237Feb 24 05:08 PM
Buckley RobertChief Financial OfficerFeb 20 '26Sale140.881,423200,46793,814Feb 24 05:08 PM
Glastra MatthijsChief Executive OfficerFeb 10 '26Sale145.047,5001,087,80057,367Feb 12 04:12 PM
Matthijs GlastraOfficerFeb 10 '26Proposed Sale145.007,5001,087,500Feb 10 12:16 PM
Glastra MatthijsChief Executive OfficerFeb 02 '26Sale135.156,500878,45964,867Feb 04 04:14 PM
Matthijs GlastraOfficerFeb 02 '26Proposed Sale135.156,500878,461Feb 02 04:30 PM
Buckley RobertChief Financial OfficerJan 21 '26Option Exercise14.131,42320,10792,457Jan 23 04:17 PM
Buckley RobertChief Financial OfficerJan 21 '26Sale140.141,423199,42491,034Jan 23 04:17 PM
Glastra MatthijsChief Executive OfficerJan 21 '26Sale140.007,5001,050,00071,367Jan 23 04:14 PM
Robert J. BuckleyAffiliateJan 21 '26Proposed Sale131.1043,9205,757,912Jan 21 04:21 PM
Matthijs GlastraOfficerJan 21 '26Proposed Sale140.007,5001,050,000Jan 21 04:04 PM
Glastra MatthijsChief Executive OfficerJan 09 '26Sale130.006,177803,01078,867Jan 13 04:07 PM
Glastra MatthijsChief Executive OfficerJan 08 '26Sale130.1432342,03585,044Jan 12 04:10 PM
Matthijs GlastraOfficerJan 09 '26Proposed Sale130.006,177803,010Jan 09 12:10 PM
Matthijs GlastraOfficerJan 08 '26Proposed Sale130.0032341,990Jan 08 04:08 PM
Secor Thomas NDirectorDec 22 '25Sale120.1674789,7600Dec 23 04:06 PM
Secor Thomas NDirectorDec 22 '25Proposed Sale120.1674789,760Dec 22 10:20 AM
Secor Thomas NDirectorDec 15 '25Sale119.6774889,513747Dec 17 04:06 PM
Secor Thomas NDirectorDec 15 '25Proposed Sale119.6774889,513Dec 15 11:13 AM
Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment enagages in the designing, manufacturing and marketing of laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles to customers worldwide. The Medical Solutions segment is involved in the designing, manufacturing and marketing of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, imaging, identification and RFID solutions, advanced motion control solutions, light engines, and integrated operating room technologies. The company was founded in 1968 and is headquartered in Bedford, MA.
CEO & Chairman of the BoardMr. Matthijs Glastra
Chief Financial OfficerMr. Robert J. Buckley
General Counsel & Corporate SecretaryMr. Alexander Manganiello
Co-Chief Operating Officer of Automation Enabling TechnologiesMr. Charles G. Ravetto
Co-Chief Operating Officer of Medical SolutionsMr. John Lesica